Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Automated Behavioral Experiments in Mice Reveal Periodic Cycles of Task Engagement within Circadian Rhythms.

Francis NA, Bohlke K, Kanold PO.

eNeuro. 2019 Sep 5. pii: ENEURO.0121-19.2019. doi: 10.1523/ENEURO.0121-19.2019. [Epub ahead of print]

2.

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary.

Shapiro CL, Yarom N, Peterson DE, Bohlke K, Saunders DP.

J Oncol Pract. 2019 Aug 26:JOP1900384. doi: 10.1200/JOP.19.00384. [Epub ahead of print] No abstract available.

PMID:
31449435
3.

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A.

J Clin Oncol. 2019 Aug 5:JCO1901461. doi: 10.1200/JCO.19.01461. [Epub ahead of print]

PMID:
31381464
4.

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.

Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP.

J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22.

PMID:
31329513
5.

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

Bohlius J, Bohlke K, Lazo-Langner A.

J Oncol Pract. 2019 Jul;15(7):399-402. doi: 10.1200/JOP.19.00111. Epub 2019 Jun 4. No abstract available.

PMID:
31162997
6.

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

Blood Adv. 2019 Apr 23;3(8):1197-1210. doi: 10.1182/bloodadvances.2018030387. Review.

7.

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10.

PMID:
30969847
8.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary.

Lyman GH, Bohlke K, Cohen L.

J Oncol Pract. 2018 Aug;14(8):495-499. doi: 10.1200/JOP.18.00283. No abstract available.

PMID:
30096271
9.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline.

Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L.

J Clin Oncol. 2018 Sep 1;36(25):2647-2655. doi: 10.1200/JCO.2018.79.2721. Epub 2018 Jun 11.

PMID:
29889605
10.

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, Omel JL, Rainey JM, Rebulla P, Rowley SD, Troner MB, Anderson KC.

J Clin Oncol. 2018 Jan 20;36(3):283-299. doi: 10.1200/JCO.2017.76.1734. Epub 2017 Nov 28.

PMID:
29182495
11.

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Schiffer CA, Bohlke K, Anderson KC.

J Oncol Pract. 2018 Feb;14(2):129-133. doi: 10.1200/JOP.2017.028902. Epub 2017 Nov 28. No abstract available.

PMID:
29182492
12.

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline Summary.

Gilligan T, Bohlke K, Baile WF.

J Oncol Pract. 2018 Jan;14(1):42-46. doi: 10.1200/JOP.2017.027144. Epub 2017 Sep 15. No abstract available.

PMID:
28915077
13.

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.

Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein RM, Finlay E, Jackson VA, Lathan CS, Loprinzi CL, Nguyen LH, Seigel C, Baile WF.

J Clin Oncol. 2017 Nov 1;35(31):3618-3632. doi: 10.1200/JCO.2017.75.2311. Epub 2017 Sep 11. Review.

PMID:
28892432
14.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Hesketh PJ, Bohlke K, Kris MG.

J Oncol Pract. 2017 Dec;13(12):825-830. doi: 10.1200/JOP.2017.026351. Epub 2017 Aug 24. No abstract available.

PMID:
28837374
15.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH.

J Clin Oncol. 2017 Oct 1;35(28):3240-3261. doi: 10.1200/JCO.2017.74.4789. Epub 2017 Jul 31. Review.

PMID:
28759346
16.

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI.

Gynecol Oncol. 2016 Oct;143(1):3-15. doi: 10.1016/j.ygyno.2016.05.022. Epub 2016 Aug 8.

17.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI.

J Clin Oncol. 2016 Oct 1;34(28):3460-73. doi: 10.1200/JCO.2016.68.6907. Epub 2016 Aug 8.

18.

Reply to J. Jupp et al.

Hesketh PJ, Bohlke K, Kris MG.

J Clin Oncol. 2016 Sep 20;34(27):3353. doi: 10.1200/JCO.2016.68.6147. Epub 2016 Jul 18. No abstract available.

PMID:
27432934
19.

Innovations in American Society of Clinical Oncology Practice Guideline Development.

Somerfield MR, Bohlke K, Browman GP, Denduluri N, Einhaus K, Hayes DF, Khorana AA, Miller RS, Mohile SG, Oliver TK, Ortiz E, Lyman GH.

J Clin Oncol. 2016 Sep 10;34(26):3213-20. doi: 10.1200/JCO.2016.68.3524. Epub 2016 Jul 5.

PMID:
27382097
20.

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Hesketh PJ, Bohlke K, Kris MG.

J Oncol Pract. 2016 Jan;12(1):88-89. doi: 10.1200/JOP.2015.009282. No abstract available.

PMID:
29424580
21.

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG; American Society of Clinical Oncology.

J Clin Oncol. 2016 Feb 1;34(4):381-6. doi: 10.1200/JCO.2015.64.3635. Epub 2015 Nov 2.

PMID:
26527784
22.

Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Smith TJ, Bohlke K, Armitage JO.

J Oncol Pract. 2015 Nov;11(6):511-513. doi: 10.1200/JOP.2015.006742. No abstract available.

PMID:
29424584
23.

Preventing breast cancer now by acting on what we already know.

Colditz GA, Bohlke K.

NPJ Breast Cancer. 2015 Jul 22;1:15009. doi: 10.1038/npjbcancer.2015.9. eCollection 2015.

24.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

J Clin Oncol. 2015 Oct 1;33(28):3199-212. doi: 10.1200/JCO.2015.62.3488. Epub 2015 Jul 13. Review.

PMID:
26169616
25.

Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

Meyer LA, Bohlke K, Powell MA, Fader AN, Franklin GE, Lee LJ, Matei D, Coallier L, Wright AA.

J Clin Oncol. 2015 Sep 10;33(26):2908-13. doi: 10.1200/JCO.2015.62.5459. Epub 2015 Jul 6.

PMID:
26150442
26.

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Lyman GH, Bohlke K, Falanga A; American Society of Clinical Oncology.

J Oncol Pract. 2015 May;11(3):e442-4. doi: 10.1200/JOP.2015.004473. Epub 2015 Apr 14. Review. No abstract available.

PMID:
25873061
27.

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology.

J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20.

28.

Breast cancer risk accumulation starts early: prevention must also.

Colditz GA, Bohlke K, Berkey CS.

Breast Cancer Res Treat. 2014 Jun;145(3):567-79. doi: 10.1007/s10549-014-2993-8. Epub 2014 May 13. Review.

29.

Priorities for the primary prevention of breast cancer.

Colditz GA, Bohlke K.

CA Cancer J Clin. 2014 May-Jun;64(3):186-94. doi: 10.3322/caac.21225. Epub 2014 Mar 19. Review.

30.

Screening for colorectal cancer: using data to set prevention priorities.

Colditz GA, McGowan LD, James AS, Bohlke K, Goodman MS.

Cancer Causes Control. 2014 Jan;25(1):93-8. doi: 10.1007/s10552-013-0311-0. Epub 2013 Oct 22.

31.

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.

Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1154-1159.e3. Epub 2007 Jul 23.

32.

Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.

Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P, Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):736-45.

PMID:
17192842
33.

Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.

Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, Simons FE.

Ann Allergy Asthma Immunol. 2006 Nov;97(5):596-602. Review.

PMID:
17165265
34.

Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.

Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF.

J Infect Dis. 2005 Jun 15;191(12):2002-7. Epub 2005 May 12.

PMID:
15897984
35.

Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety.

Mullooly J, Drew L, DeStefano F, Maher J, Bohlke K, Immanuel V, Black S, Lewis E, Ray P, Vadheim C, Lugg M, Chen R.

Methods Inf Med. 2004;43(2):163-70.

PMID:
15136866
36.

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS; Vaccine Safety Datalink Team.

J Allergy Clin Immunol. 2004 Mar;113(3):536-42.

PMID:
15007358
37.

Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?

Bohlke K, Galil K, Jackson LA, Schmid DS, Starkovich P, Loparev VN, Seward JF.

Obstet Gynecol. 2003 Nov;102(5 Pt 1):970-7.

PMID:
14672472
38.

Risk of anaphylaxis after vaccination of children and adolescents.

Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, Mullooly JP, Thompson RS; Vaccine Safety Datalink Team.

Pediatrics. 2003 Oct;112(4):815-20.

PMID:
14523172
39.

Archaeal DNA replication: spotlight on a rapidly moving field.

Böhlke K, Pisani FM, Rossi M, Antranikian G.

Extremophiles. 2002 Feb;6(1):1-14. Review.

PMID:
11878556
40.

Measles vaccination and inflammatory bowel disease: controversy laid to rest?

Davis RL, Bohlke K.

Drug Saf. 2001;24(13):939-46. Review.

PMID:
11735650
41.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
42.

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project.

Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R; Vaccine Safety Datalink Team.

Arch Pediatr Adolesc Med. 2001 Mar;155(3):354-9.

PMID:
11231801
43.

Does influenza vaccination prevent asthma exacerbations in children?

Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy SM; Vaccine Safety Datalink team.

J Pediatr. 2001 Mar;138(3):306-10.

PMID:
11241034
44.

PCR performance of the B-type DNA polymerase from the thermophilic euryarchaeon Thermococcus aggregans improved by mutations in the Y-GG/A motif.

Böhlke K, Pisani FM, Vorgias CE, Frey B, Sobek H, Rossi M, Antranikian G.

Nucleic Acids Res. 2000 Oct 15;28(20):3910-7.

45.

Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy MS.

Arch Fam Med. 2000 Jul;9(7):617-23.

PMID:
10910309
46.

Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Bohlke K, Ward JI, Marcy MS, Okoro CA.

Vaccine. 2000 Apr 28;18(21):2288-94.

PMID:
10717349
47.

Structural and functional characterization of Kv6.2 a new gamma-subunit of voltage-gated potassium channel.

Zhu XR, Netzer R, Böhlke K, Liu Q, Pongs O.

Receptors Channels. 1999;6(5):337-50.

PMID:
10551266
48.

Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists.

Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE.

Am J Epidemiol. 1999 Aug 15;150(4):354-8.

PMID:
10453811
49.

Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece.

Bohlke K, Spiegelman D, Trichopoulou A, Katsouyanni K, Trichopoulos D.

Br J Cancer. 1999 Jan;79(1):23-9.

50.

Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.

Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS.

Epidemiology. 1998 Sep;9(5):570-3.

PMID:
9730040

Supplemental Content

Loading ...
Support Center